go-flag: bridge therapy to allo-sct in r/r aml
Published 4 years ago • 87 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
2:31
optimal pcr responses and survival of patients with cbf-aml treated with flag-ida or flag-go
-
4:15
using mrd to guide post-allosct treatment decisions in aml
-
8:57
outcomes of sct in t-all and t-lbl
-
3:26
aml19 trial: flag-ida-go vs da-go in standard-risk aml and flag-ida vs cpx-351 in high-risk aml
-
4:57
flag-ida plus venetoclax induction and consolidation in newly diagnosed patients with aml
-
0:38
optimal time for allo-hsct in aml
-
3:49
venetoclax with flag-ida for aml
-
6:44
the current landscape for the treatment of r/r aml in the post-transplant setting
-
9:41
cvskl: happy birthday tan sri 2020
-
5:42
needle-free blood glucose readings? (ceatec 2019)
-
25:24
hybrid angiography ct system: pushing the boundaries
-
22:27
[tctap 2024] wrap-up interview - left main, multi-vessel diseases
-
1:29
the current landscape of maintenace therapy in aml and areas for future exploration
-
40:34
[tctap 2023] live case #18: tavr
-
3:40
master class in transplantation and hematology: highlights
-
1:21:01
[tctap 2024] live case 10: valve-in-valve, complex tavr
-
2:44
the global expansion of modern aml therapy through the international consortium on acute leukemia
-
1:47
shared treatment decision-making
-
3:54
a case study from the ecog-e1910 trial: early blinatumomab treatment in all
-
1:01
looking forward to isal 2023
-
0:35
tct 2021: what to look forward to
-
1:49
bringing precision medicine and mrd into clinical strategies